SIMPRAZOL ® - 20
INGREDIENT :
Each enteric coated tablet contains Esomeprazole magnesium trihydrate equivalent to Esomeprazole 20 mg.
INDICATION :
SIMPRAZOL® is indicated for:
Gastroesophageal Reflux Disease (GERD)
- Treatment for erosive reflux esophagitis
- Long-term treatment for patients who have recovered from esophagitis, to prevent recurrence
- Symptomatic treatment for Gastroesophageal Reflux Disease (GERD)
- In combination with an appropriate antibacterial therapeutic regimen for the eradication of Helicobacter pylori
- Healing of duodenal ulcers associated with Helicobacter pylori
· Patients who require further therapy Non-Steroidal Anti-Inflammatory (NSAID)
- Healing of gastric ulcers associated with NSAID therapy
- Prevention of gastric and duodenal ulcers associated with continued NSAID therapy in at-risk patients. Patients considered at risk due to age (> 60 years) and history of peptic ulcer. It is recommended to be given no more than 6 months.
Maintaining hemostasis and preventing rebleeding of gastric or duodenal ulcers following therapy with liquid proton pump inhibitors via intravenous infusion
Treatment of Zollinger Ellison's Syndrome
DOSAGE AND USAGE :
Tablets should be swallowed whole with water. Tablets should not be chewed or crushed.
1 x daily 20-40 mg.
DOSAGE FORM AND PACKAGING :
Box, content 2 blisters @ 10 enteric coated tablets
DKL 2228211415A1
